Exact Mass: 359.2494012000001
Exact Mass Matches: 359.2494012000001
Found 137 metabolites which its exact mass value is equals to given mass value 359.2494012000001,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
napelline
LSM-1634 is a kaurane diterpenoid. Napelline is a natural product found in Aconitum karakolicum, Aconitum baicalense, and other organisms with data available. 12-Epinapelline is a kaurane diterpenoid. 12-Epinapelline is a natural product found in Aconitum napellus, Delphinium leroyi, and other organisms with data available. Annotation level-1 12-Epinapelline is a diterpene alkaloid isolated from Aconitum baikalense. 12-Epinapelline exhibits Anti-inflammatory activity and stimulates the growth of colonies from fibroblast precursors[1][2]. 12-Epinapelline is a diterpene alkaloid isolated from Aconitum baikalense. 12-Epinapelline exhibits Anti-inflammatory activity and stimulates the growth of colonies from fibroblast precursors[1][2].
N-Palmitoyl Cysteine
C19H37NO3S (359.2494012000001)
N-palmitoyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Cysteine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Myristoyl Methionine
C19H37NO3S (359.2494012000001)
N-myristoyl methionine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Methionine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Methionine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Methionine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Eicosapentaenoyl Glycine
N-eicosapentaenoyl glycine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Glycine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Glycine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Glycine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Eptastigmine
C21H33N3O2 (359.25726380000003)
7alpha-Hydroxyparavallarine
A natural product found in Kibatalia laurifolia.
Luciculine
Origin: Plant; Formula(Parent): C22H33NO3; Bottle Name:Napelline; PRIME Parent Name:Napelline; PRIME in-house No.:V0349; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid
(S,S)-3-CBZ-3,6-DIAZABICYCLO[3.2.0]HEPTANE
C21H33N3O2 (359.25726380000003)
Cyclomethycaine
C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tridecanoate
(12R)-12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxytridecanoate
(1R,2R,4S,5S,7R,8R,9R,10S,13R,16S,17R)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.15,8.01,10.02,8.013,17]nonadecane-4,7,16-triol
(1R,2R,4S,5S,7R,8R,9R,10R,13R,16S,17R)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.15,8.01,10.02,8.013,17]nonadecane-4,7,16-triol
(1R,2S,4S,5S,7R,8R,9R,10R,13R,16S,17S)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.15,8.01,10.02,8.013,17]nonadecane-4,7,16-triol
(1R,4S,5S,7R,8R,9R,10R,13R,16S,17S)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.15,8.01,10.02,8.013,17]nonadecane-4,7,16-triol
oscr#22(1-)
A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#22, obtained by deprotonation of the carboxy group; major species at pH 7.3.
11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol
(1r,2s,5r,8r,9r,10s,11r,13r,14s,15r,16r)-7-ethyl-5-methyl-12-methylidene-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-2,11,14-triol
(3r,5s)-3-[(1r,2r,4as,8as)-2,3,6-trimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl]-5-(2-methylpropyl)-4,5-dihydropyrrole-2,3-diol
(1r,7r,10r,18s,22r,23s)-15-hydroxy-11-methyl-5-oxa-13-azahexacyclo[11.9.1.0¹,⁷.0⁷,¹⁵.0¹⁰,²³.0¹⁸,²²]tricosan-4-one
7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl carbamoylformate
(1r,5r,6r,7r,8s,9r,13r,16s,17s)-11-ethyl-7,16-dihydroxy-6,13-dimethyl-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-4-one
(1s,5r,8r,10r,11s,14s,16r,17r)-7-(2-hydroxyethyl)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-12-ol
(1s,2s,4s,5r,7r,8r,9s,10s,13s,16r,17s)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol
(1s,2s,4s,6r,7s,10r,11r)-6-hydroxy-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-8-one
2-{6,8-dihydroxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-13-yl}acetaldehyde
(1r,5r,8r,10s,11r,14s,16r,17r,18s)-7-(2-hydroxyethyl)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-18-ol
11-ethyl-4,16-dihydroxy-6,13-dimethyl-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-7-one
(1s,2s,4r,7s,8r,10r,11r)-8-hydroxy-13-(2-hydroxyethyl)-11-methyl-19-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-one
8-deoxy-14-dehydro-aconosine
{"Ingredient_id": "HBIN013704","Ingredient_name": "8-deoxy-14-dehydro-aconosine","Alias": "NA","Ingredient_formula": "C22H33NO3","Ingredient_Smile": "CCN1CC2CCC(C34C2CC(C31)C5CC(C6CC4C5C6=O)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14994","TCMID_id": "5165","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
ajaconine
{"Ingredient_id": "HBIN014950","Ingredient_name": "ajaconine","Alias": "NA","Ingredient_formula": "C22H33NO3","Ingredient_Smile": "CC12CCCC34C1CC(C56C3CC(CC5)C(=C)C6O)OC4N(C2)CCO","Ingredient_weight": "359.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "782","TCMSP_id": "NA","TCM_ID_id": "7099;19458;21460","PubChem_id": "133562510","DrugBank_id": "NA"}
7''-ethyl-6-methyl-4'',7''-dihydro-3''h-dispiro[oxane-2,6'-[7,9,12]triazatricyclo[6.3.1.0⁴,¹²]dodecane-10',2''-oxepin]-7'-ene
C21H33N3O2 (359.25726380000003)
(1s,5r,8s,9s,11r,13r,14s,15s,17r,18s)-7-(2-hydroxyethyl)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-13,15-diol
(1r,2s,4s,6r,7r,8r,10s,11r,12r)-12-ethoxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadec-13-ene-6,8-diol
12-ethyl-14-methyl-6-methylidene-12-azahexacyclo[8.7.1.1⁵,⁸.0¹,¹¹.0²,⁸.0¹⁴,¹⁸]nonadecane-4,7,17-triol
(1s,2r,4s,5r,7r,8r,10s,11r,14r,17s,18r)-12-ethyl-14-methyl-6-methylidene-12-azahexacyclo[8.7.1.1⁵,⁸.0¹,¹¹.0²,⁸.0¹⁴,¹⁸]nonadecane-4,7,17-triol
(1s,2s,4s,6s,7r,8r,10r,11r)-13-[(1e)-2-hydroxyethenyl]-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecane-6,8-diol
5-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-n-{[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]methanimidoyl}-3-methylpent-2-enimidic acid
C21H33N3O2 (359.25726380000003)
(1r,2s,5r,9r,10s,11r,13r,14s,15r,16r)-7-ethyl-5-methyl-12-methylidene-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-2,11,14-triol
2-[(1s,2s,4s,6s,7r,8r,10r,11r)-6,8-dihydroxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-13-yl]acetaldehyde
(1r,2s,4s,6r,7s,10s,11r)-6-hydroxy-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-12-one
(1r,2s,5r,8s,9r,10s,11r,13r,14s,15s,16r)-7-ethyl-5-methyl-12-methylidene-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecane-2,11,14-triol
(1s,2r,4r,7r,8s,9r,13s,16s,17r)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol
(2s,3as,3bs,6s,6ar,7s,9ar,11ar)-7,8,11-trimethyl-6-(2-methylpropyl)-1h,2h,3h,6h,6ah,7h,9ah,11ah-indeno[5,4-d]isoindole-2,3a,4-triol
7-(2-hydroxyethyl)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-13,15-diol
(1s,2s,5s,6r,7s,10s,12r,16s)-7,8,12-trimethyl-5-(2-methylpropyl)-13-oxa-4-azapentacyclo[12.2.1.0²,⁶.0²,¹⁰.0¹²,¹⁶]heptadeca-3,8-diene-1,3-diol
(2e)-5-[(1s)-2,2-dimethyl-6-methylidenecyclohexyl]-n-{[(1-hydroxy-3-methylbut-2-en-1-ylidene)amino]methanimidoyl}-3-methylpent-2-enimidic acid
C21H33N3O2 (359.25726380000003)
(1s,2s,4r,7r,10r,11r,18s)-18-hydroxy-13-(2-hydroxyethyl)-11-methyl-19-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-one
1,11-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,10h,11h,12h-cyclonona[d]isoindol-13-one
3-[(1s,4r,5r,8r,9r,12s,13s,14s,18s)-8-hydroxy-5,9-dimethyl-11-azahexacyclo[9.6.1.0¹,¹⁴.0⁴,¹⁸.0⁵,¹³.0⁸,¹²]octadecan-13-yl]propanoic acid
(1r,2s,4r,5r,6s,8r,9r,10r,13r,16s,17r)-11-ethyl-4,16-dihydroxy-6,13-dimethyl-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-7-one
(1s,3e,5s,10r)-15-ethyl-1,5-dihydroxy-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16)-dien-14-one
(1s,5r,8r,9s,11r,13r,14s,15s,17r,18s)-7-(2-hydroxyethyl)-5-methyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-13,15-diol
(1r,4s,5s,7r,8r,9r,10r,13r,16s)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol
(1'r,2s,4's,6s,7''r,10'r)-7''-ethyl-6-methyl-4'',7''-dihydro-3''h-dispiro[oxane-2,6'-[7,9,12]triazatricyclo[6.3.1.0⁴,¹²]dodecane-10',2''-oxepin]-7'-ene
C21H33N3O2 (359.25726380000003)
n-{[(2s,5e,6r,8r,9s,11s,12s)-8-(4-hydroxybutyl)-12-(prop-2-en-1-yl)-1,7-diazatetracyclo[7.3.1.0²,⁷.0⁶,¹¹]tridecan-5-ylidene]methyl}ethanimidic acid
C21H33N3O2 (359.25726380000003)
7,8,12-trimethyl-5-(2-methylpropyl)-13-oxa-4-azapentacyclo[12.2.1.0²,⁶.0²,¹⁰.0¹²,¹⁶]heptadeca-3,8-diene-1,3-diol
n-{[(5e)-8-(4-hydroxybutyl)-12-(prop-2-en-1-yl)-1,7-diazatetracyclo[7.3.1.0²,⁷.0⁶,¹¹]tridecan-5-ylidene]methyl}ethanimidic acid
C21H33N3O2 (359.25726380000003)
2,2,2-trifluoro-1-[2-methyl-3-(tridec-5-en-1-yl)-4,5-dihydropyrrol-1-yl]ethanone
7,8,11-trimethyl-6-(2-methylpropyl)-1h,2h,3h,6h,6ah,7h,9ah,11ah-indeno[5,4-d]isoindole-2,3a,4-triol
(1r,2s,4r,5r,7r,8r,9r,10r,13r,16s,17r)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol
(3s,3ar,4s,6as,11s,13ar)-1,11-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,10h,11h,12h-cyclonona[d]isoindol-13-one
(2r,4ar,7s,8as,10as)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,6,8,8a,9,10,10a-octahydro-2h-phenanthren-2-yl carbamoylformate
(3s,5s)-3-[(1s,2s,4ar,8ar)-2,3,6-trimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl]-5-(2-methylpropyl)-4,5-dihydropyrrole-2,3-diol
(1r,2r,4s,5r,7r,8r,9r,10r,13r,16s,17r)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol
(1s,5r,8r,10r,11s,12r,14s,16r,17r)-7-(2-hydroxyethyl)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-12-ol
8-hydroxy-13-(2-hydroxyethyl)-11-methyl-19-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-one
2,2,2-trifluoro-1-{2-methyl-3-[(5z)-tridec-5-en-1-yl]-4,5-dihydropyrrol-1-yl}ethanone
(2r,4r,5r,7r,8r,13r,16s,17r)-11-ethyl-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecane-4,7,16-triol
(3s,3ar,4s,6as,11r,13ar)-1,11-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,7h,10h,11h,12h-cyclonona[d]isoindol-13-one
(3s,5s)-3-[(1s,2r,4as,8ar)-2,3,6-trimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl]-5-(2-methylpropyl)-4,5-dihydropyrrole-2,3-diol
(2s,3as,3bs,6s,6ar,7s,9as,11ar)-7,8-dimethyl-11-methylidene-6-(2-methylpropyl)-1h,2h,3h,6h,6ah,7h,9ah,10h,11ah-indeno[5,4-d]isoindole-2,3a,4-triol
(3s,5s)-3-[(1r,2r,4as,8as)-2,3,6-trimethyl-1,2,4a,5,8,8a-hexahydronaphthalene-1-carbonyl]-5-(2-methylpropyl)-4,5-dihydropyrrole-2,3-diol
15-ethyl-1,5-dihydroxy-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16)-dien-14-one
2-[(1s,2r,4s,6s,7r,8r,10s,11r)-6,8-dihydroxy-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-13-yl]acetaldehyde
3-[(1r,2r,7s,10r,11r,13r,15s,17r)-17-isopropyl-11-methyl-14-oxa-16-azapentacyclo[11.3.1.0²,¹¹.0³,⁷.0¹⁰,¹⁵]heptadec-3-en-2-yl]propanoic acid
(1's,2r,4'r,6r,7''s,10's)-7''-ethyl-6-methyl-4'',7''-dihydro-3''h-dispiro[oxane-2,6'-[7,9,12]triazatricyclo[6.3.1.0⁴,¹²]dodecane-10',2''-oxepin]-7'-ene
C21H33N3O2 (359.25726380000003)